Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Brian Angus

Newcastle AuthorsTitleYearFull text
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al.		Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients2013
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Dr Susan Proctor
Kate McCabe
et al.		Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy2011
Professor Mary Slatter
Dr Brian Angus
Dr Kevin Windebank
Professor Sophie Hambleton
Dr Mario Abinun
et al.		Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency2011
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Professor Stephen Proctor
Dr Brian Angus
Dr Stephen Crosier
Dr John Anderson
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr John Anderson
Lynne Overman
Dr Katrina Wood
Professor Stephen Proctor
Dr Stephen Crosier
et al.		Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics2009
Dr Kevin Windebank
Dr Brian Angus
Dr Mario Abinun
Dr Terence Flood
Professor Andrew Cant
et al.		Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency2009
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Brian Angus
Professor Stephen Proctor
et al.		A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22008
Dr Kevin Windebank
Dr Brian Angus
Dr Petra Dildey
Dr Mario Abinun
Dr Terence Flood
et al.		Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency2008
Seamus Kelly
Dr John Anderson
Dr Brian Angus
Dr Christine Challen
Professor John Lunec
The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer2008
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Stephen Crosier
Dr Brian Angus
et al.		A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22007
Dr Brian Angus
Dr Patrick Kesteven
Localized reactive angioendotheliomatosis2007
Dr Penelope Taylor
Dr Kevin Windebank
Dr Helen Lucraft
Dr Katrina Wood
Dr Brian Angus
et al.		Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents2007
12345678